A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61P 9/00 (2006.01) A61P 25/14 (2006.01)
Patent
CA 2568158
The present invention relates to the treatment of motoneuron diseases. More particularly the invention relates to the treatment of amyotrophic lateral sclerosis (ALS). It is found that the intracerebroventricular delivery of low amounts of vascular endothelial growth factor into a preclinical ALS animal model induces a significant motor performance and prolongation of survival time of said animals.
L'invention concerne un traitement de maladies des motoneurones. En particulier, l'invention concerne le traitement de la sclérose latérale amyotrophique (SLA). Dans l'invention, on a découvert que l'administration intracérébroventriculaire de faibles quantités d'un facteur de croissance endothéliale vasculaire dans un modèle animal SLA préclinique induit une performance moteur et une prolongation significatives de la durée de vie des animaux ayant subi ce traitement.
Carmeliet Peter
D. Collen Research Foundation Vzw
Fetherstonhaugh & Co.
Life Sciences Research Partners Vzw
Vib Vzw
LandOfFree
Treatment of amyotrophic lateral sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of amyotrophic lateral sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of amyotrophic lateral sclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398104